Billionaire Mason Hawkins’ 10 Small-Cap Stocks with Huge Upside Potential

Page 9 of 9

1. Enovis Corporation (NYSE:ENOV)

Market Capitalization: $2.00 billion

Number of Hedge Fund Holders: 36

Southeastern Asset Management Stake: $1,605,262

Analyst Upside Potential: 79.49%

Enovis Corporation (NYSE:ENOV) is an international medical technology company that specializes in orthopedic solutions. Its core businesses include Prevention & Recovery solutions and Reconstructive solutions. The company mainly generates its revenue from designing and manufacturing medical technologies including orthopedic implants, bracing, supports, and surgical solutions.

On April 3, Analyst Vik Chopra of Wells Fargo reiterated a Buy rating on the stock with a price target of $59. One of the key reasons behind the analyst’s bullish sentiment is the appointment of the new CEO, Damien McDonald. The new CEO brings experience from his previous leadership roles in medical technology and orthopedic systems.  Moreover, the analyst also noted that the company has reiterated its fiscal Q1 guidance reflecting a strong revenue and EBITDA.

During fiscal 2024 the company achieved net sales of $2.1 billion, reflecting a 23% increase year-over-year. This was driven by exceptional growth in the Reconstructive segment with global revenues growing 59% during the same time. The Reconstructive segment benefited from a recent acquisition of Lima which helped enhance the product and technology portfolio. Enovis Corporation (NYSE:ENOV) is one of the best billionaire Mason Hawkins’ 10 small-cap stocks with huge upside potential.

Diamond Hill Small Cap Fund stated the following regarding Enovis Corporation (NYSE:ENOV) in its Q3 2024 investor letter:

“Other bottom Q3 contributors included Allient, Rimini Street and Enovis Corporation (NYSE:ENOV). Shares of innovative medical technology company Enovis underperformed amid investors’ disappointment with its US surgical business growth, which slowed dramatically as the company focuses on integrating recent acquisition Lima. However, given the product overlap and different sales channels, we aren’t surprised at these disruptions and believe the acquisition will prove beneficial in the long run.”

While we acknowledge the potential of ENOV to grow, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ENOV but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure. None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9